Showing 1 - 2 results of 2 for search 'Anwen Xiong', query time: 0.01s Refine Results
  1. 1
    Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study

    Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study by Chenyu Mao, Anwen Xiong, Jiong Qian, Wenxiang Wang, Ying Liu, Tao Zhang, Zhihai Wu, Haiqing Ni, Jia Lu, Sixiang Long, Li Zhao, Yuling Chen, Caicun Zhou, Nong Xu

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Camrelizumab, an Anti‐PD‐1 Monoclonal Antibody, Plus Carboplatin and Nab‐Paclitaxel as First‐Line Setting for Extensive‐Stage Small‐Cell Lung Cancer: A Phase 2 Trial and Biomarker Analysis

    Camrelizumab, an Anti‐PD‐1 Monoclonal Antibody, Plus Carboplatin and Nab‐Paclitaxel as First‐Line Setting for Extensive‐Stage Small‐Cell Lung Cancer: A Phase 2 Trial and Biomarker... by Jia Yu, Deyu Cai, Sha Zhao, Lei Wang, Xinlong Zheng, Anwen Xiong, Qi Wang, Bin Chen, Menghang Yang, Wei Li, Yan Wang, Jiajia Yuan, Changhong Zhao, Wei Shi, Caicun Zhou, Luonan Chen, Tao Jiang, Xiaohui Chen, Shengxiang Ren

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: